New Search

If you are not happy with the results below please do another search

32 search results for:

21

Preparing for EU Joint Clinical Assessment 2025

Preparing for EU Joint Clinical Assessment 2025: Leveraging Gen AI Technology to Navigate the New Era in Health Technology Assessment   As we edge closer to 2025, the pharmaceutical landscape in Europe is poised for a transformative change with the implementation of the new EU Health Technology Assessment (HTA) regulations. This pivotal move, aimed at harmonizing [...]
22

Pharma WhatsApp communications with physicians

Solutions WhatsApp Business API for Pharma & Physician Communications While pharmaceutical organizations and the healthcare sector have been becoming increasingly more digitalized, it was the COVID-19 pandemic that accelerated the need for much faster adoption and agility, including digital communication channels between pharma organizations and healthcare professionals. The healthcare sector, together with hospitals, physicians and [...]
23

Insights from Generative AI Implementations: 4 Focus Areas

Solutions 9 Months In: Insights from Generative AI Implementations in Pharma & Biotech - Our 4 Focus Areas In an age of rapid technological breakthroughs, the usage of artificial intelligence has progressed beyond mere buzzwords to become an essential component of company operations. A subclass of AI known as generative AI has enormous promise, allowing [...]
24

Bespoke ChatGPT for compliant, impactful patient & healthcare professionals engagement

Solutions Bespoke ChatGPT for compliant, impactful patient & healthcare professionals engagement Contact us now for a live-demo In today's rapidly evolving healthcare landscape, effective communication between pharmaceutical companies, patients, healthcare professionals (HCPs), and nurses is paramount. To bridge the gap and deliver exceptional customer experiences, a groundbreaking solution has emerged: Custom ChatGPT using Pharma-owned & [...]
25

Rapid scaling & agile organization to deliver results

Whether the fast launch of a pharma product, a rapid business assessment, tapping into a network of experts in a specific therapy area, engaging a new medical target audience or developing and running a promotional campaign – we have the expertise and capabilities to support you and create solutions that work. On time, within your budget and delivering results.

26

International market access & pricing

Securing broad access to a novel therapy is essential for launch success. Building on deep therapy area insights, we facilitated early and constructive engagement with payers in key countries, allowing to identify the key evidence needs in time. Leveraging our broad international network, we brought the relevant players to the table, allowing the company to make informed decisions in time.

27

Engaging training and communication

Communicating complex content within the organization by developing efficient and impactful micro-learning snippets that engage team members. A solution to enable staff to learn on-demand and on-the-go, empowering individuals to fill knowledge gaps. Self-checks make it easier to track progress and motivate participants.

28

Digital engagement and transformation in Medical Affairs

Medical content to support clinical decision making, rapid medical support, access to experts and providing individualized content are expected from Medical Affairs. The pandemic has accelerated digitalization and engaging in virtual settings. Platforms and tools need to support to engage effectively with medical content, personalize the experience, generate evidence and improve access.

29

Smart (ai enhanced) KOL identification and engagement

Key Opinion Leaders (KOLs) shape medical practice and define therapeutic areas. Identifying who to work with and how to engage with them is essential for pharma and biotech companies. Based on insights from more than 50 launches and 15 different therapy areas, we have co-created with pharma and biotech companies a smart, ai enhanced platform to identify the most important KOLs, engage strategically and with full compliance.

30

Launch of a medical device with an agile organization

The first six months of a product launch reliably predict its peak sales (Strategies for successful drug launches)*. Large companies and start-ups face the challenge of securing market access, ensuring product availability, building brand awareness while investing at a competitive level. With our flexible network of experts in key markets, we bring the needed capabilities and competencies to the table to ensure a timely and effective launch.